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Estimation of Pulmonary Motion in
Healthy Subjects and Patients with
Intrathoracic Tumors Using 3D-Dynamic
MRI: Initial Results
Objective: To estimate a new technique for quantifying regional lung motion
using 3D-MRI in healthy volunteers and to apply the technique in patients with
intra- or extrapulmonary tumors. 
Materials and Methods: Intraparenchymal lung motion during a whole breath-
ing cycle was quantified in 30 healthy volunteers using 3D-dynamic MRI (FLASH
[fast low angle shot] 3D, TRICKS [time-resolved interpolated contrast kinetics]).
Qualitative and quantitative vector color maps and cumulative histograms were
performed using an introduced semiautomatic algorithm. An analysis of lung
motion was performed and correlated with an established 2D-MRI technique for
verification. As a proof of concept, the technique was applied in five patients with
non-small cell lung cancer (NSCLC) and 5 patients with malignant pleural
mesothelioma (MPM). 
Results: The correlation between intraparenchymal lung motion of the basal
lung parts and the 2D-MRI technique was significant (r = 0.89, p < 0.05). Also, the
vector color maps quantitatively illustrated regional lung motion in all healthy vol-
unteers. No differences were observed between both hemithoraces, which was
verified by cumulative histograms. The patients with NSCLC showed a local lack
of lung motion in the area of the tumor. In the patients with MPM, there was global
diminished motion of the tumor bearing hemithorax, which improved siginificantly
after chemotherapy (CHT) (assessed by  the 2D- and 3D-techniques) (p < 0.01).
Using global spirometry, an improvement could also be shown (vital capacity 2.9
± 0.5 versus 3.4 L ± 0.6, FEV1 0.9 ± 0.2 versus 1.4 ± 0.2 L) after CHT, but
this improvement was not significant. 
Conclusion: A 3D-dynamic MRI is able to quantify intraparenchymal lung
motion. Local and global parenchymal pathologies can be precisely located and
might be a new tool used to quantify even slight changes in lung motion (e.g. in
therapy monitoring, follow-up studies or even benign lung diseases).
n many pulmonary pathology cases, the compliance of lung tissue
increases locally or globally, leading to clinical symptoms such as dyspnea
in the end (1, 2). A key aspect of pulmonary physiology that can be
measured using MRI is lung motion. Surrogate measures based on the motion of the
chest wall and diaphragm have been reported (3-5); and, can be compared to conven-
tional pulmonary function tests such as spirometric local information of, for example,
the hemithorax. 
Grid-tagging techniques allow for the direct assessment of regional motion and local
mechanical properties of moving structures in the human body (6, 7). However, there
are limitations due to the relatively low spatial resolution of the estimated motion
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Ifields, stemming from the coarse grid intervals that are
currently practicable. Another problem is the fading of the
grid due to the T1 decay time of the tissue and the
difficulty of applying the method in 3D. In addition, 3D-
imaging techniques covering a whole volume and not just a
certain aspect or dimension as in 2D-imaging techniques
might be the technique of choice, which, so far are
frequently suffering from a lack of sufficient temporal
resolution (8). Thus 3D techniques are still the focus of
scientific research (8, 9). 
Recently, a new approach has been proposed using a
dense motion field as a potential indirect parameter of lung
compliance (10, 11). Using MRI, this technique was
introduced in a small group of healthy subjects with limited
temporal resolution. Using a similar technique, it could be
shown that the motion of pulmonary nodules during the
breathing cycle can be quantified (9). A 3D-quantification
of the motion of the lung parenchyma during the breathing
cycle has not been quantified or visualized so far. 
In this study we propose a technique using dynamic 3D-
MRI sequences with high temporal resolution and a new
semiautomatic post-processing tool to quantify
intraparenchymal lung motion. For verification the 3D-
imaging technique was correlated with an established 2D-
technique; this approach has been successfully applied and
quantified in pulmonary volume research during the
breathing cycle (12). Additionally, the introduced
technique was applied in patients with intra- (solitary
intrapulmonary) and extrapulmonary (malignant pleural
mesothelioma) malignancies to evaluate the potential to
detect differences or changes in local and global
intraparenchymal pulmonary motion. 
MATERIALS AND METHODS
Prior to enrolment, the investigation protocol was
approved by the institutional human research ethic
committee. Twenty-five healthy young non-smoking
volunteers (18 male and 7 female; median age, 28 years;
range 22 - 33 years) and five healthy elderly non-smoking
volunteers (3 male and 2 female; median age, 61 years;
range 58 - 62 years) without any evidence or history of
pulmonary disease, were included in this study. In
addition, five patients (3 male and 2 female; median age,
63 years, range 60 - 65 years) with a histologically proven
intrathoracic solitary stage I non-small cell lung cancer
(NSCLC) were included in this study (maximum axial
diameter 3.5 ± 1.6 cm; localization: upper lung part: 3,
middle lung part: 2 [4, 13]). No therapeutical treatment
had been performed before the MRI examination. Stage I
patients were chosen to guarantee certain intrathoracic
restrictions in pulmonary motion.
Lastly, five patients with a histologically proven stage II
malignant pleural mesothelioma (MPM; 3 male and 2
female; median age, 60 years; range 58 - 63 years) were
included in this study (stage II = T2 N0 M0 = tumor
involves any of the ipsilateral pleural surface with at least
one of the following: confluent visceral pleural tumor
(including fissure), invasion of diaphragmatic muscle,
invasion of lung parenchyma. Stage II patients were chosen
to guarantee certain extrathoracic restrictions in
pulmonary mobility. Upon histological verification of the
tumor, we determined that no treatment had been
performed before chemotherapy (CHT; combination of
pemetrexed and cisplatin [14]). Patients were investigated
before CHT and after three out of six cycles (9 weeks).  
After the nature of the procedure had been fully
explained, informed consent was signed by all participants
under an institutionally approved subject research
protocol. 
MRI
All examinations were performed using a clinical 1.5T
whole-body scanner (Magnetom Symphony, Siemens
Medical Solutions, Erlangen, Germany) equipped with
eight receiver channels, a six channel coil and a high
performance gradient system (30 mT/m) (8, 9). 
For lung motion examination dynamic breathing MRI
were performed as follows (Fig. 1):
3D+t (dynamic 3D-MRI = 3D-MRI during the breathing
cycle [9, 12]). 
An MRI was performed using an isotropic time-resolved
3D gradient echo pulse sequence. In this study, the view
sharing methods used, have been proven to be suitable in
the investigation of the lung and lung tumor motion (8-10,
15). In this technique some parts of k-space are updated
more often than other k-spaces, leading to an effective
shortening of the total acquisition time. For 3D-applica-
tions, the view sharing implementation, time-resolved
interpolated contrast kinetics (TRICKS), was introduced
(15) and applied as per the manufacturer’s instructions
(SIEMENS). In TRICKS, the low frequency k-space data
which contributes most significantly to the image content is
sampled more frequently than the high frequency k-space
data which is interpolated between consecutive time
frames (FLASH [fast low angle shot] 3D; TR/TE = [repeti-
tion time/echo time]: 1.54/0.59 msec, flip angle = 10� ,
receiver bandwidth = 1,500 Hz/pixel; GRAPPA accelera-
tion factor = 3, FOV [field of view]: 375×400 mm, matrix
= 77×128, slab thickness = 198 mm, 52 partitions, voxel
size = 4.87×3.13×3.8 mm
3). Consecutive data sets were
acquired over 20 seconds during the following breathing
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exhale before the start of the measurement and to slowly
breathe in to maximum inspiration (within 5 seconds)
during the measurement and, once again, to exhale slowly.
Thus, MRI measurements started at the maximum expira-
tory level and covered continuous maximum inspiration
and maximum expiration. A slow breathing maneuver was
performed to account for the low temporal resolution of
one 3D dataset per second. This procedure was rehearsed
several times to ensure a reproducible execution. All
subjects were instructed to breathe uniformly for the MRI. 
2D-Dynamic MRI
In recent studies, it has been shown that there are signifi-
cant correlations between 3D- and 2D-dynamic MRI
techniques (8, 14). A 2D-MRI technique was used for
comparison with the introduced 3D-MRI technique
because of the better temporal resolution and the less time-
consuming quantification process. For a 2D-dynamic MRI,
a fast imaging with a steady precession (trueFISP) pulse
sequence using the following applied imaging parameters
(4): TE/TR = 1.7/37.3 ms, flip angle 65� , receiver
bandwidth 977 Hz pixel 21, GRAPPA acceleration factor
= 2, reference k-space lines for calibration 31, FOV = 375
×400 mm, matrix 112×192, slice thickness 10 mm. View
sharing was not used for the 2D-method. Three frames per
second (scan time per frame is 0.33 s) were acquired within
an acquisition time of 30 s. All patients were instructed to
change from quiet tidal breathing to maximal inspiration
and maximal expiration, as in 3D- imaging. 
Analysis
Quantification of lung motion
While 2D+t MRI image sequences offer enough detail
from the intraparenchymal region for image based non-
rigid registration, 3D+t image sequences suffer from a low
signal-to-noise ratio and virtually no morphological
information from within the lungs (8, 9, 14). Thus, when
applying non-rigid registration methods to 3D+t image
sequences acquired as described above, the calculated
motion information does not necessarily correspond to the
real motion of the parenchyma. Depending on the degree
of regularization applied during the algorithmic solution of
the registration problem, it represents either an interpola-
tion of the motion observed at areas with reliable image
information (mostly outside of the lung), or a quantifica-
tion of the motion of local image noise.
Thus, we have elaborated an alternative approach for
the approximation of local parenchymal motion during the
respiratory cycle by the interpolation of a dense vector
field from a set of points residing on the surface of the
lung. These point set correspondences are established
automatically by means of a statistical shape model. In the
following, it will be briefly summarized as to which steps
are performed in the estimation of motion information
from a set of consecutive 3D-images.
In medical image processing, a statistical shape model
may be used to solve the problem of segmentation in cases
where the desired object has a reasonably known shape.
While for a human being it is straightforward to recognize
the three-dimensional shape of an object, it is a challenging
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Fig. 1. Motion information of healthy subject covering whole breathing cycle. 
A. Color map shows absolute strength of motion (maximum extension from end-inspiration to end-expiration). Upon comparison, it can
clearly be seen that most substantial symmetric intraparenchymal motion is in lower parts of lung. 
B. Cumulative motion histogram shows relative motion of lung to its maximum.
ABtask to represent shape information in a way that a
computer understands. Therefore, the principle of statisti-
cal shape modeling has been introduced (16). Given a set
of training shapes where each shape in the training set is
represented by a set of labeled landmark points which
must be consistent from one shape to the next, a statistical
shape model is calculated. Such a model consists of the
mean shape across all training shapes, combined with the
associated variance information. Additionally, this shape
information may be combined with information about the
gray-value appearance of each of the training shapes. This
way, segmenting the desired object in new image data
corresponds to finding model parameters which minimize
the difference between the image and a synthesized model
example, projected into the image. The segmentation result
is typically represented as a mesh where each vertex
corresponds to one of the labelled landmark points. By
applying such a shape-based segmentation method to a
temporal series of consecutive images, one gains anatomic
correspondence information, because corresponding
vertices in the segmentation result should approximately
be located at the same anatomic positions. 
The shape-based segmentation approach used in this
work is based on the work of Heimann et al. (17), who
combined the shape information from a statistical shape
model with a locally deformable model. This extends the
applicability of the segmentation method to a broader
range of data sets, including shape variations that have not
been observed in the set of training shapes. Using the
methods described by Heimann et al. (18), we have built
statistical shape models of the left and right lung from 180
lung segmentations in all includes subjects. Each shape
model consists of a set of 1,000 points. As a certain gold
standard maximum motion of the basal lung parts, using an
established quantitative 2D-MRI-technique, was applied
(4) and compared with the introduced technique. The
whole training dataset has been segmented by a radiologi-
cal expert. 
The workflow for calculating dense vector fields from a
3D+t image sequence has been implemented in an interac-
tive software environment based on our open-source
toolkit for interactive medical image processing applica-
tions, MITK (Medical Imaging Interaction Toolkit) (19).
There, the following steps have to be performed: First, a
3D-surface model representing the mean model of the lung
is positioned roughly within the first data set of the time
series. Then, the shape-based segmentation algorithm
automatically segments the lung within that dataset. The
segmentation result may be verified and corrected if
necessary. Then, this initial segmentation is propagated
automatically to all other time steps of the image sequence
by applying the segmentation result of the previous time
step as initialization of the shape model in the current time
step. As a result of the segmentation process, a series of
corresponding points (1,000 for every time step) is
generated. This correspondence information gives detailed
information about the motion of the lung surface. A dense
vector field representing the motion from one time step to
the next may be calculated by initializing an elastic body
spline transformation (EBS-transform) with correspon-
dence information from the landmarks. An EBS-transform
maps a set of landmark locations in one image onto a
corresponding set on a second image-based on the theory
of deformable bodies. For a time series of N images, a set
of N-1 vector fields is calculated, revealing detailed
information about the local motion of the lung. 
Data Analysis
To facilitate an intuitive way of interpretation for the
vector fields, motion information is coded into a color map
by accumulating all the motion information onto the first
time step of the image sequence. The motion of each single
voxel within the lung is tracked over time and the total
distance (end inspiration to end expiration as for the 2D-
technique) that is covered by this voxel is color coded. The
absolute motion of the voxel and lung parenchyma is
shown. The color maps are rendered as transparent
overlays onto the original images. Additionally, the vector
fields can be displayed explicitly in a three-dimensional
view by arrow representations.
When the data of one patient should be assessed in
follow-up examinations or in a comparison of the hemitho-
races, it is hard to compare motion information because
intra-individual differences of the magnitude of the breath-
ing maneuver cannot be distinguished from potential
changes due to treatment response. Normally, there is no
substantial difference between the hemithoraces in healthy
subjects. Thus, we propose an alternative strategy by
expressing the strength of the motion in the diseased
hemithorax, relative to the strength of motion in the
healthy hemithorax. Additionally, motion information is
normalized to its relative strength. This way, the individual
motion pattern can be displayed in a cumulative histogram,
which relates the relative strength of the motion to the
proportion of the lung in which motion, smaller or equal to
the given strength, can be observed.
To get an impression of what can be regarded as a
‘normal’ non-pathologic motion pattern, a mean cumula-
tive motion histogram has been calculated.
In this proof-of-principle study, a group of healthy
volunteers was investigated and color maps and cumula-
tive motion histograms were performed. Results were
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with MPM. 
For 2D-dynamic MRI lung motion examination, coronal
planes crossing the trachea were acquired in each patient
(4). Motion of the lung was measured from the apex of the
lung to the diaphragmatic dome in the craniocaudal (CC)
plane in the middle of the hemithorax. Maximum displace-
ment was defined as the maximum difference between
deep inspiration and expiration using MRI. 
Statistical Analysis
Statistical analyses were performed using the SAS
software (SAS Institute Inc., Cary, NC). To obtain simulta-
neous tests for the mean comparisons, the Duncan’s
multiple-range test of analysis of variance on the signifi-
cance level of p = 0.05 was used. The mean and standard
deviation were calculated. In addition, a t-test performed
on paired samples was performed. Further, a correlation of
the 2D- dynamic MRI data with 3D-dynamic MRI data was
investigated by a Spearman’s correlation. For the correla-
tion maximum, craniocaudal motion of the basal lung parts
was measured using a 2D-dynamic MRI (4) and a 3D-
dynamic MRI and was tested to determine whether a
correlation between the two modalities was evident. Voxel
motion was defined as the maximum motion of a voxel
(mm) during respiration. Statistical significance was set at p
< 0.05.
RESULTS
In all healthy subjects, information on local and global
lung parenchymal motion could be visualized and
estimated (color map, Fig. 1A). Maximum lung motion
(motion of the voxel that moves greatest distance) in the
basal lung parts was about 9.2 ± 3.1 cm and no significant
difference between both hemithoraces was found. The
associated motion trajectory was calculated over each
voxel and then visualized. A relative cumulative motion
histogram showed the same information (Fig. 1B). Using
the 2D-dynamic MRI technique, maximum CC motion was
determined to be 8.8 ± 3.5 cm, which represented no
significant difference between the hemithoraces. A correla-
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Fig. 3. MRI depiction of parenchymal lung motion.
A. Patient with solitary non-small cell lung cancer in upper right lung. 
B. Using simple vector field representation for one time frame of breathing cycle, limited lung motion in right upper lung can hardly be
seen. 
C. Using color map representation of breathing cycle, from maximum expiration to maximum inspiration, limited asymmetric lung motion
can clearly be seen. In this patient, overall lung motion was limited because of limited lung function. 
AB C
Fig. 2. Mean cumulative relative motion histogram calculated
over 30 healthy volunteers. Dotted lines indicate corresponding
standard deviations.tion between the 3D- and 2D-MRI measurement of
maximum motion in the basal lung parts was found to be
significant (r = 0.89, p < 0.05, Table 1). 
Motion Model
The mean cumulative relative motion histogram and
standard deviations, calculated from 30 healthy volunteers,
is shown in Figure 2. In healthy persons, similar motion
patterns can be expected for the left and right lungs. An
analysis comparing younger to older healthy individuals
indicated no significant difference (p = 0.31).
Patient with Non-Small Cell Lung Cancer
Cumulative vectorial and color maps are not shown in
the group of patients because of the different localizations
of the tumors and thus different influences on the
intraparenchymal lung motion at different localizations. In
Table 1, maximum craniocaudal motions of the basal lung
parts are shown. Intraparenchymal lung motion during
respiration is shown using vectorial and color map
techniques (Fig. 3). A substantial restriction of the lung
motion around the tumor can be observed. 
Patient with Malignant Pleural Mesothelioma
Intraparenchymal lung motion during respiration is
shown using the color map technique, before and after
therapy (Fig. 4). A substantial restriction of the whole
intraparenchymal lung motion in comparison with healthy
volunteers (Fig. 1), is shown. A slight improvement of lung
mobility can be observed after therapy. In Table 1,
Plathow et al.
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Fig. 4. Patient with malignant pleural
mesothelioma in left hemithorax before
(left) and after (right) chemotherapy.
Substantial restriction of left-sided
intrapulmonary motion can be observed.
After therapy, lung motion increased
slightly and in good correlation with
improved lung function.
Table 1. Maximum Motion of Basal Lung Parts
Maximum Motion of Basal Lung Parts (cm) 2D-Dynamic MRI 3D-Dynamic MRI Using Color Maps
Healthy volunteer 8.8 ± 3.5 9.2 ± 3.1
Patient with a solitary NSCLC
- healthy hemithorax 8.5 ± 3.1 8.2 ± 3.4
- hemithorax with NSCLC 7.8 ± 3.5 7.5 ± 3.1
Patient with MPM, before CHT
- healthy hemithorax 8.8 ± 3.1 9.1 ± 2.9
- hemithorax with MPM *2.6 ± 1.0* *2.5 ± 1.1*
Patient with MPM, after CHT
- healthy hemithorax 8.9 ± 2.9 8.9 ± 2.8
- hemithorax with MPM *4.3 ± 1.6* *4.5 ± 1.5*
Note.─ As there was no significant level of maximum motion of basal lung parts in healthy volunteers, there is only one value. In patients with solitary 
non-small cell lung carcinoma and patients with malignant pleural mesothelioma before and after chemotherapy, hemithorax is subdivided based on
presence of tumor or not. Follow-up of patients with malignant pleural mesothelioma indicated significant improvement in maximum motion of basal lung
parts of hemithorax with malignant pleural mesothelioma, which could be proven using 2D- and 3D-techniques, as well as in end volumetry. Correlation
between 2D- and 3D-dynamic MRI using color maps was significant in all cases (p < 0.01). 
(* significant change [p < 0.01], 2D-dynamic MRI p = 0.009, 3D-dynamic MRI p = 0.08) 
NSCLC = non-small cell lung carcinoma, MPM = malignant pleural mesothelioma, CHT = chemotherapy absolute data concerning the maximum CC motion
indicate a significant improvement of the motion of the
MPM-bearing hemithorax. This improvement was also
found by clinically performed pulmonary function tests
(vital capacity 2.9 ± 0.5 versus 3.4 ± 0.6 L, FEV1 0.9 ±
0.2 versus 1.4 ± 0.2 L), but was not proven to be signifi-
cant.
The cumulative relative motion histogram for the same
patient (Fig. 5), indicates a decrease in lung motion in the
left lung before therapy is apparent. The increase in lung
mobility after therapy is demonstrated as a shift of the
motion curves to the right. 
DISCUSSION
The results of this study indicate that a dynamic 3D-MRI,
using a parallel imaging technique in combination with an
introduced post-processing technique, is able to quantify
intraparenchymal lung motion during the breathing-cycle
in healthy volunteers and patients with intra- and extrapul-
monary tumors. According to recent studies significant
correlations between 2D- and 3D-imaging techniques
could be proven (12); however, these studies have focused
only on extrapulmonary structures (e.g. the thorax and the
diaphragm). In this study, the measurement of
intraparenchymal dimensions indicated a significant
correlation between 2D- and 3D-techniques. The
established 2D-technique (4, 5), which measures the
motion of extrapulmonary landmarks, was applied and
proven to show significant correlations with the proposed
3D-technique by accurately measuring intraparenchymal
lung motions, especially of the basal lung parts. It might be
argued that both techniques measured two different
aspects and thus were not comparable. However so, it is
only to a certain degree. The 2D-technique measured
absolute dimensions (e.g. maximum extension from in- to
expiration using extrapulmonary landmarks), as did the
3D-technique, but did so using intraparenchymal voxels.
Both techniques showed similar measurements, which was
verified in the basal lung parts. In summary, both absolute
quantifications showed a significant correlation and the
established 2D-technique proved to be a suitable and
simple technique to check and prove the validity of the
3D-technique. Using the 3D-technique, significant local
and global intraparenchymal pulmonary differences during
the breathing cycle could be demonstrated, which might be
of interest in future research e.g. in the field of therapy
monitoring or follow-up investigations of pulmonary
diseases. Using global lung function tests (in this case:
spirometry in patients with MPM), substantial changes in
lung function could be quantified. However, due to the
inherent deficit to quantify local changes, these changes
were not significant compared with local MRI-techniques. 
It might be argued that the authors focused on malignant
intra- and extrapulmonary tumors to investigate the
introduced technique measuring motion of the lung. The
reasoning behind this decision was attributed to the
authors intentions to investigate the introduced technique
in two established lung disease models, where an influence
on lung motion using MRI has already been proven in the
past (13, 20). The extension of this technique, even on
benign pulmonary diseases, might be of interest in further
research.  
Many approaches exist, when it comes to quantifying
lung motion, especially in radiotherapy. These approaches
generally focus on the quantification of the changes of
extrapulmonary structures, such as the thoracic wall or the
diaphragm. One frequent approach is to use fluoroscopy
(21); but, as a projection technique, it is very imprecise and
lung parenchyma can hardly be visualized. CT has also
been proposed in this field (10, 22), but has the inherent
limitation of radiation exposure (23). The recent develop-
ment of fast dynamic MRI techniques has made possible,
detailed, non-invasive imaging of pulmonary parenchyma
by overcoming the inherent difficulties associated with
lung imaging, including low proton density, severe
magnetic field susceptibility, and respiratory and cardiac
motion artifacts. Thus, MRI has been described as a tool
used to quantify lung and tumor motion during respiration
(9, 24). It could be shown that MRI is able to encompass
the whole thorax and to directly assess impaired respira-
tory mechanics without using X-rays; an important aspect,
especially in follow-up examinations and benign diseases.
Gee et al. (11) introduced the 2D-MRI to quantify regional
lung strain. It could be demonstrated that knowledge of
lung motion is a new way to quantify lung mechanics and
Lung Motion Estimation in Healthy Subjects and Pulmonary Tumor Patients Using 3D-Dynamic MRI
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Fig. 5. Cumulative relative motion histogram for patient with 
malignant pleural mesothelioma (from Fig. 4). Following therapy,
slight increase of overall lung motion, especially left side, can be
observed.thus regional lung function. Thus far, 3D-techniques have
not been investigated. 
As observed by Sarrut et al. (10) and Remouchamps et
al. (25), using CT, there were lower parenchymal displace-
ments in the upper lung regions than in the lower parts. In
contrast to a CT, where standardized Hounsfield units can
be used to support the segmentation process, automatic
MRI-based segmentation is a more challenging task. Recent
developments in the area of shape-based segmentation
have helped to overcome these problems, thus facilitating
a fully automatic segmentation of the lungs, even in noisy
data. As an inherent property of all shape-based segmenta-
tion methods, shape correspondence can be established
either between the shape model and the image by
segmenting the image or even between two images by the
segmentation of both images using the same shape model.
This opens a wide field for image analysis requiring
correspondence information, as is the case for motion
estimation. However, there are also several aspects of this
method which have to be discussed. On the one hand, the
main limitation is that motion information is estimated by
interpolating internal motion from motion at the surface of
the lung. On the other hand, having no further information
available about the internal structure of the lung
parenchyma, this is a reasonable approach as a first step
towards establishing applicability of elastic body splines
and 3D+t motion information at all. If internal structures
are clearly visible in all time steps using enhanced image
sequences, the method could easily be extended to add
these internal landmarks to the set of corresponding
landmarks. This way, local internal parenchymal motion
could also be modeled. The presented method represents a
novel, semi-automated way to evaluate lung motion in
three dimensions over time. This was proven in a series of
healthy subjects. For verification, we used an established
2D-MRI technique. Also significant correlation was found
between the 2D- and 3D-methods and the results were
similar to recent results, verified by spirometry (4). 
In the next step we investigated whether the technique is
able to show changes of intraparenchymal lung motion in
patients with intra- and extrapulmonary tumors. Recently,
it has been shown that intrapulmonary tumors have a
significant influence on lung motion of the tumor bearing
hemithorax (9). In this study it has been proposed that
regional disorders of the lung motion by lung tumors might
be a reason for the disorder of the lung compliance.
Comparing tumor bearing with the non-tumor bearing
hemithorax supports this observation; especially in the
area around the tumor where a substantial decrease in lung
motion could be observed. This decrease might be caused
by the infiltrative and retractive effects of the tumor, and
requires further research. 
In patients with extrapulmonary tumors (e.g. pleural
mesothelioma), restriction of the mobility of the tumor
bearing the hemithorax can be expected (26). In this study,
we could show that an extrapulmonary tumor mass leads
to a substantial global decrease in lung mobility and thus
intraparenchymal motion. Additionally, it could be proven
that significant changes of this decrease in intraparenchy-
mal lung mobility after CHT can be shown using the
proposed MRI technique, and verified by spirometry. 
Still, a major limitation in using 3D-MRI techniques is the
limited temporal resolution of one image per second. The
investigator is hardly dependent on the good breathing
compliance of the patient. Even though this temporal
resolution proved to be suitable in the past research of
patients with pulmonary diseases (9, 12), an improvement
in the temporal as well as the spatial resolution must be
recommended to better cover a whole breathing cycle,
especially in tidal breathing. 
If this new technique is sensitive enough to examine
slight changes during a follow-up examination of a bigger
group of patients, it might have the potential to be an early
predictor of therapy response, however this needs to be
proven in further research. Also the potential to assist in
the detection of early, localized, and benign pathologies
(e.g. fibrotic diseases at a stage not influencing spirometry)
has recently been published, however measuring
pulmonary volumetric dimensions (27) has to be verified in
further research.  
In conclusion, the dynamic 3D-MRI in combination with
a novel post-processing technique has shown to be a usable
3D-tool for the quantification of intraparenchymal lung
motion. This technique is able to show differences between
the intraparenchymal lung motion of healthy volunteers
and patients with intra- and extrathoracic lung diseases,
and thus might have the potential to be a tool to investi-
gate slight changes of local and global pulmonary mechan-
ics. 
References
1. Petty TL, Silvers GW, Stanford RE. Mild emphysema is associ-
ated with reduced elastic recoil and increased lung size but not
with air-flow limitation. Am Rev Respir Dis 1987;136:867-871
2. Clausen JL. The diagnosis of emphysema, chronic bronchitis and
asthma. Clin Chest Med 1990;11:405-416
3. Suga K, Tsukuda T, Awaya H, Takano K, Koike S, Matsunaga
N, et al. Impaired respiratory mechanics in pulmonary
emphysema: evaluation with dynamic breathing MRI. J Magn
Reson Imaging 1999;10:510-520
4. Plathow C, Ley S, Fink C, Puderbach M, Heilmann M, Zuna I,
et al. Evaluation of chest motion and volumetry during the
breathing cycle by dynamic MRI in healthy subjects: comparison
with pulmonary function tests. Invest Radiol 2004;39:202-209
Plathow et al.
566 Korean J Radiol 10(6), Nov/Dec 20095. Plathow C, Fink C, Ley S, Puderbach M, Eichinger M, Schma ¨hl
A, et al. Measurement of diaphragmatic length during the
breathing cycle by dynamic MRI: comparison between healthy
adults and patients with an intrathoracic tumor. Eur Radiol
2004;14:1392-1399
6. Axel L, Dougherty L. MR imaging of motion with spatial
modulation of magnetization. Radiology 1989;171:841-845
7. Napadow VJ, Mai V, Bankier A, Gilbert RJ, Edelman R, Chen
Q. Determination of regional pulmonary parenchymal strain
during normal respiration using spin inversion tagged magneti-
zation MRI. J Magn Reson Imaging 2001;13:467-474
8. Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M.
Time-resolved contrast-enhanced three-dimensional magnetic
resonance angiography of the chest: combination of parallel
imaging with view sharing (TREAT). Invest Radiol 2005;40:40-
48
9. Plathow C, Schoebinger M, Fink C, Hof H, Debus J, Meinzer
HP, et al. Quantification of lung tumor volume and rotation at
3D dynamic parallel MR imaging with view sharing: preliminary
results. Radiology 2006;240:537-545
10. Sarrut D, Boldea V, Ayadi M, Badel JN, Ginestet C, Clippe S, et
al. Nonrigid registration method to assess reproducibility of
breath-holding with ABC in lung cancer. Int J Radiat Oncol Biol
Phys 2005;61:594-607
11. Gee J, Sundaram T, Hasegawa I, Uematsu H, Hatabu H.
Characterization of regional pulmonary mechanics from serial
magnetic resonance imaging data. Acad Radiol 2003;10:1147-
1152
12. Plathow C, Schoebinger M, Fink C, Ley S, Puderbach M,
Eichinger M, et al. Evaluation of lung volumetry using dynamic
three-dimensional magnetic resonance imaging. Invest Radiol
2005;40:173-179
13. Plathow C, Ley S, Fink C, Puderbach M, Hosch W, Schma ¨hl A,
et al. Analysis of intrathoracic tumor mobility during the whole
breathing cycle by dynamic MRI. Int J Radiat Oncol Biol Phys
2004;59:952-959
14. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C,
Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in
combination with cisplatin versus cisplatin alone in patients with
malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-
2644
15. Du J, Bydder M. High-resolution time-resolved contrast-
enhanced MR abdominal and pulmonary angiography using a
spiral-TRICKS sequence. Magn Reson Med 2007;58:631-635
16. Cootes TG, Taylor CJ, Cooper DH, Graham J. Active shape
models - their training and application. Comput Vis Image
Underst 1995;61:38-59
17. Heimann T, Mu ¨nzing S, Meinzer HP, Wolf I. A shape-guided
deformable model with evolutionary algorithm initialization for
3D soft tissue segmentation. Inf Process Med Imaging
2007;20:1-12
18. Heimann T, Wolf I, Meinzer HP. Automatic generation of 3D
statistical shape models with optimal landmark distributions.
Methods Inf Med 2007;46:275-281
19. Wolf I, Vetter M, Wegner I, Bo ¨ttger T, Nolden M, Scho ¨binger
M, et al. The medical imaging interaction toolkit. Med Image
Anal 2005;9:594-604
20. Plathow C, Klopp M, Schoebinger M, Thieke C, Fink C,
Puderbach M, et al. Monitoring of lung motion in patients with
malignant pleural mesothelioma using two-dimensional and
three-dimensional dynamic magnetic resonance imaging:
comparison with spirometry. Invest Radiol 2006;41:443-448
21. Hof H, Herfarth KK, Mu ¨nter M, Hoess A, Motsch J,
Wannenmacher M, et al. Stereotactic single-dose radiotherapy
of stage I non-small-cell lung cancer (NSCLC). Int J Radiat
Oncol Biol Phys 2003;56:335-341
22. Hof H, Herfarth KK, Mu ¨ nter M, Essig M, Wannenmacher M,
Debus J. The use of the multislice CT for the determination of
respiratory lung tumor movement in stereotactic single-dose
irradiation. Strahlenther Onkol 2003;179:542-547
23. Shirato H, Oita M, Fujita K, Watanabe Y, Miyasaka K.
Feasibility of synchronization of real-time tumor-tracking
radiotherapy and intensity-modulated radiotherapy from
viewpoint of excessive dose from fluoroscopy. Int J Radiat
Oncol Biol Phys 2004;60:335-341
24. Plathow C, Fink C, Ley S, Puderbach M, Eichinger M, Zuna I, et
al. Measurement of tumor diameter-dependent mobility of lung
tumors by dynamic MRI. Radiother Oncol 2004;73:349-354
25. Remouchamps VM, Letts N, Yan D, Vicini FA, Moreau M,
Zielinski JA, et al. Three-dimensional evaluation of intra- and
interfraction immobilization of lung and chest wall using active
breathing control: a reproducibility study with breast cancer
patients. Int J Radiat Oncol Biol Phys 2003;57:968-978
26. Eibel R, Tuengerthal S, Schoenberg SO. The role of new
imaging techniques in diagnosis and staging of malignant pleural
mesothelioma. Curr Opin Oncol 2003;15:131-138
27. Plathow C, Hof H, Kuhn S, Puderbach M, Ley S, Biederer J, et
al. Therapy monitoring using dynamic MRI: analysis of lung
motion and intrathoracic tumor mobility before and after
radiotherapy. Eur Radiol 2006;16:1942-1950
Lung Motion Estimation in Healthy Subjects and Pulmonary Tumor Patients Using 3D-Dynamic MRI
Korean J Radiol 10(6), Nov/Dec 2009 567